Biotech

All Articles

ReNeuron leaving behind goal substitution after missing fundraising goal

.ReNeuron has actually signed up with the long listing of biotechs to leave behind London's purpose ...

MBX apply for IPO to take opposition to Ascendis right into phase 3

.MBX Biosciences has actually added to the recent flurry of IPO filings. The biotech, which filed it...

FDA broadens probing right into Lykos' MDMA trials: WSJ

.For Lykos Therapies as well as the company's prospective MDMA-assisted treatment for trauma (POST-T...

Gene publisher Volume giving up 131 workers

.Simply times after gene publisher Tome Biosciences declared secret operational cuts, a clearer pict...

Repare lays off 25% of staff as biotech stops preclinical R&ampD

.Repare Therapeutics is giving up a quarter of its own labor force as the oncology biotech scales ba...

J &amp J declare FDA permission of $6.5 B autoimmune medication

.Johnson &amp Johnson has actually gotten one more step toward recognizing a profit on its $6.5 bill...

Gain's phase 1 succeed paves way to prove Parkinson's medicine's worth

.Gain Therapies has set its direct showing the efficiency of its Parkinson's ailment treatment follo...

Actinogen records brand new stage 2 information to salvage anxiety medicine

.Actinogen Medical's hopes-- and supply rate-- have actually rebounded somewhat from earlier this mo...

Pfizer and Main add Quotient to multibillion-dollar formula

.Flagship Pioneering and Pfizer have actually added Ratio right into their 10-program partnership, i...

Bayer markers $547M deal to push boundaries of noncoding RNA

.Bayer execs were keen to worry to Strong this summer season that the German pharma titan's cravings...